Esperion recalls NEXLIZET 180/10 mg tablets due to failed dissolution testing at 0 months. This may affect medication effectiveness. Check NDC 72426-818-03 and lot numbers for affected products.
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
Esperion is recalling NEXLIZET (bempedoic acid and ezetimibe) tablets that failed dissolution testing. This could mean the medication isn't working as intended, which is serious for people needing cholesterol control.
The tablets failed dissolution testing at the 0-month timepoint, meaning they didn't dissolve properly when they should have. This could lead to the medication not working effectively for cholesterol management.
People prescribed NEXLIZET for high cholesterol who have the specific 30-count bottle with NDC 72426-818-03 and lot number 1990305. Those with the medication are most at risk.
Check for the NEXLIZET 180 mg/10 mg tablets in a 30-count bottle with NDC 72426-818-03 and lot number 1990305. The product is prescription-only and manufactured by Esperion.
Look for NDC 72426-818-03 and lot number 1990305 on the bottle.
The recall is due to failed dissolution testing, which may affect medication effectiveness. It is not safe to use as intended without the remedy.
The recall does not specify a remedy, so contact Esperion directly for guidance.
Check the NDC number 72426-818-03 and lot number 1990305 on the bottle.
We’ve drafted a message you can send Esperion to request your refund or repair — edit it as you like.
Subject: Recall D-0441-2024 — Esperion Esperion Hello, I own a Esperion that is covered by recall D-0441-2024 from Esperion. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
